FormDSignal
62

OrbiMed closes $1.92B private equity fund X at 131 investors

Fund raise update · Private equity / buyout · Closed · NEW YORK, NY · Form D/A filed 2026-10-16 · sponsor: OrbiMed · all Orbimed Private vehicles

OrbiMed Private Investments X, LP, a Delaware limited partnership, closed a $1.92B private equity fund with 131 investors under Regulation D exemptions 3(c)(7) and 6(b). The fund achieved its full offering amount as of September 30, 2025.

$100M+ sold3(c)(7) — qualified purchasersCapital closing nowPrivate equity / buyout

How this compares

  • $1.92B is larger than 99% of the 3,008 private equity / buyout fund launches with a stated size in the last two years; the median is $5.1M.
  • Among 1,691 fund launches filed from NY in the same window it is larger than 99%; the NY median is $5M.
  • Across 490 private equity / buyout sponsors with more than one launch on EDGAR, the median gap between consecutive funds is 5 months.
  • This is the sponsor's 2nd fund launch on EDGAR; the previous one, OrbiMed Private Investments X, LP, was filed 13 months earlier at $1.75B.

Computed from every Form D fund launch on EDGAR since late 2024, not sampled. Amounts are the stated offering size; indefinite offerings are excluded.

Raise progress

Sold rose from $1.67B to $1.92B (+$251.9M, +12 investors) in 169 days since the previous filing.

FiledFormSoldInvestorsChange
2025-09-29D$00
2026-04-30D/A$1.67B119+$1.67B
2026-10-16D/A$1.92B131+$251.9M

Amount sold and investor count as restated on each of the issuer's Form D filings. A rise since the previous filing is capital closed in between.

OrbiMed on EDGAR

Earlier and related filings by the same issuer and sponsor. All Orbimed Private vehicles →

Registered adviser

probable match

ORBIMED ADVISORS LLC

Registration
SEC-registered adviser · since 2002-04-22
Regulatory AUM
$20.6B
Employees
118
Private funds on Form ADV
24
Office
New York, NY

Website and main-office phone from Form ADV. Subscribe to unlock

This fund on Form ADV

This fund already appears on the adviser's Schedule D: gross assets, investor count and the administrator, auditor and custodian named on it. Subscribe to unlock

Service providers on the adviser's other funds

The administrator, auditor, custodian and prime broker named on this adviser's 23 other funds: whether a new mandate here is a displacement or a greenfield. Subscribe to unlock

Other Form D filings by this adviser

11 other filings on EDGAR under this adviser, with size, strategy and date. Subscribe to unlock

People on the filing

N/A OrbiMed Capital GP X, LPExecutive Officer
N/A OrbiMed Capital GP X LLCExecutive Officer
N/A OrbiMed Advisors LLCExecutive Officer
Mona AshiyaExecutive Officer
David P. BonitaExecutive Officer
Carl L. GordonExecutive Officer
Geoffrey C. HsuExecutive Officer
W. Carter NeildExecutive Officer
Matthew S. RizzoExecutive Officer
C. Scotland StevensExecutive Officer
Peter A. ThompsonExecutive Officer

[email protected] · observed Work emails for the people on the filing, where the firm publishes or patterns them, labelled by confidence — subscribers

Signed by W. Carter Neild, Member of OrbiMed Advisors.

Placement agents / sales compensation: UBS Switzerland AG; MERRILL LYNCH, PIERCE, FENNER & SMITH INCORPORATED

Why now — by persona

  • Fund audit & tax:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
  • Fund administrator:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock

Filing contact

The issuer's phone number and address from the filing are shown to subscribers. See plans.